103545-18-2 (4-L-丙氨酸胰激肽,Kallidin, 4-L-alanine-)

4-L-丙氨酸胰激肽;

Kallidin, 4-L-alanine-;H-LYS-ARG-PRO-ALA-GLY-PHE-SER-PRO-PHE-ARG-OH;Lys-(Ala?)-Bradykinin;Lys-(Ala3)-Bradykinin;LYS-ARG-PRO-ALA-GLY-PHE-SER-PRO-PHE-ARG: KRPAGFSPFR;LYS-ARG-PRO-ALA-GLY-PHE-SER-PRO-PHE-ARG;[Ala4]-Kallidin;[LYS0, ALA3]-BRADYKININ;103545-18-2;(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;

NYZLRKMHRNRLFJ-HBGYEDQKSA-N

1S/C54H83N17O12/c1-32(64-48(78)41-21-12-26-70(41)50(80)36(19-10-24-61-53(57)58)66-45(75)35(56)18-8-9-23-55)44(74)63-30-43(73)65-38(28-33-14-4-2-5-15-33)46(76)69-40(31-72)51(81)71-27-13-22-42(71)49(79)68-39(29-34-16-6-3-7-17-34)47(77)67-37(52(82)83)20-11-25-62-54(59)60/h2-7,14-17,32,35-42,72H,8-13,18-31,55-56H2,1H3,(H,63,74)(H,64,78)(H,65,73)(H,66,75)(H,67,77)(H,68,79)(H,69,76)(H,82,83)(H4,57,58,61)(H4,59,60,62)/t32-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1

O=C([C@H](CCC/N=C(\N)/N)NC([C@H](CCCCN)N)=O)N1CCC[C@H]1C(N[C@H](C(NCC(N[C@@H](CC1C=CC=CC=1)C(N[C@@H](CO)C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(=O)O)CCC/N=C(\N)/N)=O)CC1C=CC=CC=1)=O)=O)=O)=O)=O)C)=O